![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 20, 17775-17780, May 17, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S*
,
¶, and
From the
Medical Nobel Institute for Biochemistry,
Department of Medical Biochemistry and Biophysics, Karolinska
Institutet, S-171 77 Stockholm, Sweden and the § Bioprocess
Engineering Laboratory, Department of Process, Environmental
Engineering and Biocenter Oulu, University of Oulu, FIN-90014
Oulu, Finland
Received for publication, February 8, 2002, and in revised form, March 8, 2002
| |
ABSTRACT |
|---|
|
|
|---|
Escherichia coli glutaredoxin 2 (Grx2, encoded by grxB) differs greatly from the other two
glutaredoxins in structure and catalytic properties. In a wild type
strain, levels of Grx2 increased 3-fold in the stationary phase (up to
8 µg/mg). Guanosine-3',5'-tetraphoshate (ppGpp) and In Escherichia coli (E. coli), cytosolic
disulfides are kept reduced by the glutaredoxin and thioredoxin
systems. In the glutaredoxin system, electrons are transferred from
NADPH, to glutathione reductase, glutathione (GSH), and finally to the
three glutaredoxins (Grx1, Grx2, and Grx3, encoded by grxA,
grxB, and grxC, respectively). In the thioredoxin
system the flow of electrons is from NADPH to thioredoxin reductase and
finally thioredoxins 1 and 2 (Trx1 and Trx2 encoded by trxA
and trxC, respectively). Glutaredoxins catalyze
GSH-disulfide oxidoreductions usually via two redox-active cysteine
residues separated by two other amino acids (typically CPYC) (1, 2).
The oxidoreductions are either dithiol reactions to reduce protein
disulfides or monothiol reductions of mixed disulfides with
glutathione. In comparison, thioredoxins may predominantly reduce
protein disulfides. Grx1 and Grx3 are ~10-kDa proteins with
homologues in most living organisms and have the characteristic thioredoxin/glutaredoxin fold (3). Grx1 can reduce the intracellular disulfides of ribonucleotide reductase
(RR)1 and PAPS reductase,
while Grx3 has 5% of the catalytic activity of Grx1 for RR1a (4, 5).
The larger Grx2 (24.3 kDa) with one N-terminal glutaredoxin domain and
a highly helical C-terminal domain (glutathione
S-transferases-like structure) (6) cannot reduce RR but has
the highest catalytic activity using the mixed disulfide between
glutathione and The glutaredoxin and thioredoxin systems are involved in cellular
defense against oxidative stress (9-11). The transcriptional regulator
OxyR regulates major responses to oxidative stress and positively
affects transcription of gor (glutathione reductase), katE, katG (catalases), grxA, and
trxC (12-14). Grx1 and Trx1 are both able to reduce, thus
deactivate OxyR in vitro, with Grx1 being the preferred
reductant in vivo (15, 16). Expression of catalases and
glutaredoxins is interconnected. All glutaredoxins are highly elevated
in catalase deficient strains (katEkatG) (17), whereas
catalase HPI is elevated in a null mutant for
trxAgrxAgrxBgrxC (8). In the katEkatG null
mutants, Grx2 protein levels were determined to be ~3-fold higher
than in wild type cells, with levels reaching 2% (20 µg/mg) of total
cell protein in the stationary phase (8, 17).
Guanosine-3',5'-tetraphoshate (ppGpp) and Chemicals--
The sodium salt of cAMP was purchased from Sigma.
cAMP solutions were prepared fresh prior to each experiment. All other
chemicals were purchased from known commercial sources.
Strains and Plasmids--
The bacterial strains and plasmids
used in this work are listed in Table
I. Unless otherwise stated,
E. coli strains are AF1000 (MC4100 relA+) derivatives.
AF1000 is therefore considered as the wild type. Transductions were
done with phage P1 (21).
Growth Experiments and Media--
Cells were grown LB liquid
medium (22) or LB medium solidified with agar from Merck (15 g/liter)
and supplemented (whenever needed) with ampicillin (100 µg/ml),
kanamycin (50 µg/ml), tetracycline (20 µg/ml), or chloramphenicol
(20 µg/ml). For the shake flask experiments, cells were grown in LB
medium overnight at 37 °C in 10-ml cultures in 100-ml Erlenmeyer
flasks. Overnight cultures were centrifuged, resuspended, diluted to
1:200, and grown in 200 ml of glucose ammonia-based mineral salt medium
in 1L Erlenmeyer flasks (23).
Overexpression of RelA and Treatment of Cells with Hydrogen Peroxide--
Cells were grown
to late exponential phase, A600 0.7-0.8
in LB medium. Hydrogen peroxide (5 mM) was then added, and
the cells were then further cultivated for 1 h before harvesting.
Valine-induced Isoleucine Starvation--
Cells were grown in M9
medium (22) containing BME (basal medium Eagle) vitamin solution
(Invitrogen), leucine (50 µg/ml), isoleucine (50 µg/ml), and
glucose (2 g/liter). At A600 of about 0.2, valine (1 mM final concentration) was added to the
cells. Samples were taken at different time points, the bacteria
harvested, kept at Preparation of Cell-free Extracts--
Cells were harvested,
resuspended in 50 mM Tris-HCl, pH 8.0, 1 mM
EDTA, disrupted at 4 °C by sonic disintegration.
Phenylmethylsulfonyl fluoride (1 mM) was added, and lysates
were centrifuged at 13,000 × g for 30 min at 4 °C.
The supernatants of the lysates after centrifugation were used as the
material for sandwich ELISAs.
Protein Concentration Measurements--
Total protein was
measured by the method of Bradford (24). Pure protein was determined by
measuring A280. Antibody concentration was
calculated using the relation: antibody (mg/ml) = (A280-A310)/1.4.
Purification of Antibodies and Enzyme Immunoassay
(ELISA)--
Purification of antibodies against Grx2 and other
redoxins by affinity chromatography and quantification of Grx2 by
sandwich enzyme immunoassay were carried out as described previously
(17).
Viability Test--
The numbers of live and dead cells were
determined with a viability kit (LIVE/DEAD BactLight) from
Molecular Probes and analyzed using a fluorescence microscope.
Colony and Cell Count--
Growth of the cultures was followed
by measuring the optical cell density at 500 nm
(A500) (relation 1 A500 = 0.6 A600), by microscopy with a cell-counting
chamber (0.02 µm depth), and by analysis of the number of colony
forming units on LB plates. The stability of the gene marker
(grxB::kan) was controlled by replica plating on
LB and kanamycin plates.
Levels of Grx2 Are Directly Up-regulated by ppGpp--
ppGpp is
the positive regulator of the stringent response and positively affects
the general starvation response (18, 25) occurring in stationary phase.
To examine whether Grx2 expression is affected by ppGpp, we measured
levels of Grx2 in strains with altered ppGpp content. In a
spoTrelA double null mutant, levels of Grx2 at the
exponential phase were less than one-third compared with wild type, and
no increase was seen at the stationary phase of growth (Fig.
1). Since SpoT and RelA are known to be
the only cellular gene products accounting for the synthesis of ppGpp, and spoTrelA null mutants are therefore devoid of ppGpp,
these results suggest that grxB transcription is regulated
by ppGpp. To examine this possibility further, we measured the levels
of Grx2 in strains containing plasmids encoding RelA (Fig.
2). A truncated form of RelA (1-133
amino acids), known not to elevate ppGpp levels, had no effect on the
expression of Grx2. In contrast, the full-length form (733 amino acids)
resulted in a clear elevation of Grx2. A truncated form of
RelA-(1-455), which is known to positively regulate ppGpp (26),
also increased the levels of Grx2 (Fig. 2). Induction of RelA in a
spoTrelA Levels of Grx2 Are Controlled by Regulation of Trx1--
Trx1 levels were lower in the
spoTrelA
Expression of Grx1 showed a slight up-regulation in the
spoTrelA cAMP Down-regulates Levels of Grx2 at the Exponential
Phase--
cAMP, as part of the cAMP-cAMP catabolite repressor protein
complex (cAMP·CRP), down-regulates the expression of
Grx2 Levels Increase in Hyperosmotic Environments--
A clear
up-regulation of Grx2 levels occurred after treatment with NaCl (Fig.
7). As stability and translation rates of
OxyR Does Not Regulate the Expression of Grx2 and Grx3--
OxyR
regulates the transcription of a large number of genes in response to
oxidative stress (33). Levels of Grx2 and Grx3 showed no significant
change before and after treatment with hydrogen peroxide in both the
wild type and the oxyR null mutant (Fig. 8). However, the steady-state levels of
Grx2 were significantly elevated in the oxyR null mutant
(Fig. 8B). These data suggest that transcription of
grxB is independent of OxyR but dependent on an alternative
backup system. Levels of Grx1, known to be regulated by OxyR, showed an
increase of up to 6-fold in the wild type, but remained stable in the
oxyR grxB The glutaredoxin and thioredoxin systems are envisaged as
antioxidants in normal cell metabolism, in view of their ability to
reduce cytosolic disulfides. Stationary phase cells exhibit increased
amount of intracellular disulfides and carbonylated proteins compared
with exponential phase cells (34). One would therefore expect that the
thioredoxin and glutaredoxin system would adapt to the conditions of
the stationary phase by providing more reducing equivalents. Levels of
GSH (35) and glutathione reductase (14) are elevated at the stationary
phase as are other antioxidant systems including HPII (36). From the
two thioredoxins and the three glutaredoxins of the thioredoxin and
glutaredoxin systems, it is only Grx2 and Trx1 that are elevated in the
stationary phase (17). Grx1 is down-regulated, whereas Grx3 and Trx2
maintain the same levels irrespective of the cell growth phase (17). These data point to Trx1 and Grx2 as the most potential antioxidant components of the five presently known dithiol thioredoxins and glutaredoxins at the stationary phase of growth. We wanted to investigate the regulation of Grx2 during the transient from
exponential growth to starvation. There are three major responses of
E. coli entering the stationary phase: the stringent
response with ppGpp as the cellular alarmone, the general starvation
response with Grx2 expression was inhibited by cAMP at the exponential phase. As the
promoter of Grx2 lacks a binding site for the cAMP-CRP complex, it is
very unlikely that the protein is regulated by cAMP directly. cAMP is
known to function as a negative regulator for the expression of
Grx2 is involved in the response to oxidative stress, as Grx2 levels
were significantly up-regulated in catalase-deficient strains, and null
mutants for grxB have high levels of carbonylated proteins
in their cytosols (8). In this work, levels of Grx2 were highly
elevated in oxyR null mutants, although levels of Grx2 and
Grx3 are known to be down-regulated after exposure to hydrogen peroxide
(17). These findings suggest that Grx2 is not regulated by the
antioxidant defense orchestrated by OxyR but from an alternative
system. Another potential antioxidant not regulated by OxyR is the
thioredoxin-like protein NrdH, which is also up-regulated in an
oxyR The elevation of Grx2 levels to up to 1% of total cell protein (17)
combined with the high GSH levels of the stationary phase (35), and the
distorted morphology of the grxB
S,
which regulate the transcription of genes in the stationary phase,
dramatically affected the expression of Grx2. spoTrelA null
mutants, lacking ppGpp, had very low levels of Grx2, while overproduction of full-length RelA or valine-induced starvation of
isoleucine, both conditions elevating ppGpp levels, resulted in
elevation of Grx2. Null mutants for the
S-specific
protease ClpP, which have higher levels of
S, exhibited
a 3-fold Grx2 increase.
S in trans also
increased the levels of Grx2. Therefore the stationary phase expression
of Grx2 is determined by the
S-bound form of RNA
polymerase in connection with ppGpp, while basal levels should be
attributed to
70-RNA polymerase holoenzyme. Osmotic
pressure and cAMP also affected the expression of Grx2, presumably via
S. Furthermore, Grx2 levels were elevated in an
oxyR
strain. In accordance with the
role of Grx2 as a stationary phase protein, null mutants for
grxB were shown to lyse under starvation conditions and
exhibited a distorted morphology.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
-hydroxyethyl disulfide as substrate (HED assay)
(5). E. coli Grx2 has close homologues in
Actinobacillus actinomycetemcomitans (87% amino
acid identity), Neisseria meningitidis (58%),
and Vibrio cholerae (42%), all known pathogens,
but it is not a "ubiquitous" protein. All three E. coli
glutaredoxins are good electron donors for the reduction of arsenate by
arsenate reductase, with Grx2 having a 100-fold higher catalytic
efficiency (7). To identify more glutaredoxin functions, null mutants
for Grx2 (grxB) were constructed.
GrxB
strains were viable, but with 80%
lower levels of general GSH-disulfide oxidoreductase activity and an
increased sensitivity to oxidative stress (8).
S (RpoS) are
two major factors controlling the transcription of genes in stationary
phase of growth and are also known to control the transcription of
genes involved in the antioxidant response (18, 19). E. coli
glutathione reductase is positively regulated by
S in
the stationary phase (14). Trx1 transcription is positively regulated
by ppGpp, but for the trxA expression
S is
not required (20). The levels of Grx2 have been previously shown to be
growth phase dependent and highly elevated at the stationary phase of
growth (17). This made us interested in further investigating whether
ppGpp and
S regulate the expression of Grx2.
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
Strains and plasmids
S--
Transformed
cells with plasmids encoding
S (pRL40.1) or RelA
(pALS10, pALS13 and pALS14) were grown in LB with 100 µg/ml
ampicillin. Cells were induced with 150 µM IPTG for the
expression of RelA and 1 mM IPTG for the expression of
S. Samples were taken just before induction and 30, 60, and 90 min after induction. RelA expression was induced at a relatively low A600 (~0.2), while expression of
rpoS was induced at late exponential phase,
A600 0.7-0.8.
20 °C, and analyzed by ELISA after preparation
of cell free extracts.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
strain was followed by a modest increase in Grx2
expression, probably due to the low levels of ppGpp, even after
induction (data not shown). To imitate isoleucine starvation leading to
RelA-dependent accumulation of ppGpp, valine was added to
the culture medium of growing cells. The addition of valine led to
up-regulation of Grx2 levels (Fig. 3).
These data suggest that expression of Grx2 is positively regulated by ppGpp levels.

View larger version (16K):
[in a new window]
Fig. 1.
Levels of Grx2 in different E. coli null mutants. Cells were grown in minimal
salt medium, and samples were taken at late exponential phase
(A600 0.7-0.8) (1), early stationary
phase (2), after 3 h in stationary phase (3), and finally after
16 h at stationary phase (4). Levels are analyzed by ELISA, and
the values are presented as mean of triplicates and are from at least
two independent experiments.

View larger version (14K):
[in a new window]
Fig. 2.
Levels of Grx2 after induction of RelA with
150 µM IPTG. Transformed cells
(AF1000) with plasmids encoding full-length RelA-(1-743) (
),
RelA-(1-455) (
), or
RelA-(1-331) (
) were grown in LB to
early exponential phase. At A600
0.2-0.3 cells were induced with IPTG. Data represent the ELISA
analysis of two independent experiments.

View larger version (11K):
[in a new window]
Fig. 3.
Levels of Grx2 after Valine induced
isoleucine starvation. Cells (AF1000) were grown in M9 medium and
at A600 of about 0.2 cells were split
and valine (1 mM) was added to one of the cultures (
),
and the other was left as control (
). The addition of valine induces
starvation for isoleucine, which leads to RelA-dependent
accumulation of ppGpp. Data represent the ELISA analysis of two
independent experiments.
S--
Apart from
ppGpp, the rpoS-encoded sigma factor S (RpoS or
S) regulates the transcription of different genes in the
stationary phase (19). ppGpp up-regulates RpoS levels (27), and
S-dependent promoters require ppGpp for
their induction (28). To examine whether
S affects the
expression of Grx2, we measured Grx2 levels in null mutants for genes
affecting total
S content. Cells lacking
S-specific ClpP protease (clpP null mutants)
have higher
S levels (29). In this genetic background
Grx2 levels were significantly increased during all growth phases (Fig.
1), suggesting that
S may up-regulate the levels of
Grx2. The effect was more pronounced in the stationary phase where the
Grx2 levels were twice as high as in the wild type. Thus the growth
phase-dependent regulation is maintained in the
clpP mutant. To exclude that the observed effect was due to
Grx2 itself being a substrate for ClpP protease, levels of Grx2 were
measured in an rpoSclpP null mutant (Fig. 1). Levels of Grx2
were the same at the exponential phase of growth but decreased at the
stationary phase, suggesting that Grx2 is not a substrate for ClpP
protease, but its expression is rather dependent on
S.
The high levels of Grx2 at the exponential phase of the
rpoSclpP and rpoS null mutants suggest that
transcription of Grx2 is also regulated by
70 (Fig. 1).
Even under
70 transcriptional control, levels of Grx2
were much lower in the relA spoT mutant, presumably because
of the very low ppGpp levels in that strain. To further investigate
whether transcription of grxB is controlled by
S, we measured Grx2 levels in strains transformed with a
plasmid encoding rpoS under an inducible promoter. In a
rpoS
strain, induction of
S led to very modest increases in Grx2 levels,
presumably due to the already high base levels of Grx2 (data not
shown). Clear up-regulation of Grx2 upon induction of
S
was observed in the wild type strain (Fig.
4). Levels of Grx2 remained very low when
S expression was induced in a spoTrelA
strain (Fig. 4), presumably due to the low levels of ppGpp in the
particular strain.
S-dependent promoters
require ppGpp for induction of their regulated genes (28). In
conclusion, ppGpp,
S, and
70 can regulate
the expression of Grx2. ppGpp is the prerequisite for both
70 and
S, which themselves can control
the expression of Grx2 in the exponential and stationary phase,
respectively.

View larger version (12K):
[in a new window]
Fig. 4.
Levels of Grx2 after induction of
S with 1 mM IPTG
in AF1000 (Wt) and AF1005
(spoT
relA
).
Transformed cells with plasmid encoding for
S were grown
in LB, and the expression of rpoS was induced at late
exponential phase (A600 0.7-0.8).
S induced in AF1000 (
), non-induced AF1000 (
), and
S induced in AF1005 (
). Levels are analyzed by
sandwich ELISA, and the values are presented as mean of duplicates,
from two independent experiments.
strain, but showed no increase in the
clpP null mutant (Fig.
5A). These results are consistent with Trx1 being regulated by ppGpp, but not by
S (20). However, the ppGpp regulation of Trx1 differed
from that for Grx2. Levels of Trx1 in the null mutant for
spoTrelA were very low only at the stationary phase of
growth. In comparison, levels of Grx2 remain very low at all growth
stages (Fig. 1). This indicates that ppGpp regulates the expression of
Trx1 only at the stationary phase. Levels of Trx1 were increased after
induction of RelA in a wild type strain (Fig. 5B), but after
induction of
S, no effect was seen (data not shown).
These data confirm previous findings on the regulation of Trx1 in
stationary phase by ppGpp (20).

View larger version (19K):
[in a new window]
Fig. 5.
Levels of Trx1 in different null mutants and
after RelA induction. A, cells were grown in minimal
salt medium, and samples were taken at late exponential phase
(A500 0.7-0.8) (column 1),
early stationary phase (column 2), after 3 h in
stationary phase (column 3), and finally after 16 h at
stationary phase (column 4). B, cells (AF1000)
with plasmid encoding for full-length RelA (
) or
RelA-(1-331)
(
) were grown in LB to early exponential phase. At
A600 0.2-0.3 cells were induced with
IPTG. Levels are analyzed by sandwich ELISA, and the values are
presented as mean of triplicates.
strain. No effect was seen for Grx3 and Trx2 in
the strains examined for Grx2 levels (data not shown). It is therefore
unlikely that
S or ppGpp regulates Grx3 and Trx2.
S (30). Therefore, null mutants for cya
(encoding adenylate cyclase) have higher levels of
S
than the wild type even at the exponential phase of growth. Grx2 levels
were also slightly up-regulated at the exponential phase in strains
lacking cAMP (cya
strain, Fig. 1).
Addition of cAMP in a null mutant for the cya gene resulted
in a down-regulation of Grx2 at the exponential phase, while no
significant effect was observed when cAMP was added at the stationary
phase of growth in the particular strain (Fig.
6). Addition of cAMP to
cya
strains in the exponential phase of
growth is known to lead to degradation of
S (31). The
lack of CRP consensus binding sites at the promoter of grxB
together with the previous findings on the regulation of Grx2
expression by
S suggest that the effects of cAMP·CRP
on the levels of Grx2 are most likely due to changes of the
S levels.

View larger version (15K):
[in a new window]
Fig. 6.
Levels of Grx2 in a cya null
mutant (AFC) with and without addition of exogenous cAMP at different
stages of growth. Cell culture of a cya null mutant was
grown in minimal salt medium. At exponential phase
(A600 ~0.8) and at early stationary
phase of growth (A600 ~1.5), the
culture was divided and exogenous cAMP (2 or 5 mM) was
added. A600 (
), AFC (
), + 2 mM cAMP (*), +5 mM cAMP (
). Data represent
the ELISA analysis of two independent experiments.
S are increased in hyperosmotic conditions (32), it is
likely that the increases in Grx2 levels were a consequence of the
elevated
S.

View larger version (12K):
[in a new window]
Fig. 7.
Levels of Grx2 after induced osmotic chock
with 500 mM NaCl. Cell (AF1000) culture was
grown in minimal salt medium. At early exponential phase
(A600 ~0.2) the culture was divided
and to one part 500 mM NaCl was added.
, +NaCl;
,
NaCl. Levels of Grx2 were analyzed by ELISA. Values are presented as
mean of triplicates.
strain. The same was observed for
Trx2, but with a 2-fold increase.

View larger version (14K):
[in a new window]
Fig. 8.
Effect of the redoxin levels after treatment
with hydrogen peroxide in wild type compared with
oxyR
strain. Wild type
(RK4936) cells (A) and OxyR null mutant (TA4112)
(B) were grown in LB to late exponential phase
(A600 ~0.8) and treated for 1 h
with 5 mM hydrogen peroxide.
, addition of hydrogen
peroxide;
, non-treated. Data represent the ELISA analysis of two
independent experiments.
Phenotype--
MC4100grxB
null mutant had the same maximum specific growth rate as MC4100 during
growth on mineral salt medium (data not shown). During prolonged
cultivation of the grxB null mutant in the stationary phase
on glucose ammonia-based mineral salt medium, the measured
A500 remained approximately constant and
was identical to wild type strain (Fig.
9). However, the colony count on agar plates of the grxB null mutant was significantly lower than
that of the wild type strain (Fig. 9), as well as the number of cells determined by microscopic analysis (data not shown). A large number of
cells in the culture of the grxB null mutant were much
bigger than the cells of the wild type culture. Analysis of the cell viability with a fluorescence test kit showed a higher amount of
damaged cells in the grxB null mutant compared with the wild type (data not shown). We explain these observations by a higher death
rate of grxB null mutant. The dead cells would serve as a
substrate for the surviving population, causing cell division and
growth (large cells). In contrast, wild type cells after glucose starvation become smaller and also survive a long time of cultivation under starvation conditions. The hypothesis of an increased lysis of
the grxB null mutant is supported by analysis of the total protein content in the cultivation medium, which was increased in the
culture of MC4100grxB
but not in the
culture of MC4100 (Fig. 10).

View larger version (13K):
[in a new window]
Fig. 9.
Long time survival as a result of glucose
starvation in MC4100 (circle) and
MC4100grxB (square). Growth of
the cultures in minimal salt medium was followed by measuring the
optical cell density at 600 nm (white symbols) and by
analysis of the number of colony forming units on LB plates
(black symbols).

View larger version (13K):
[in a new window]
Fig. 10.
Extracellular protein concentration in
MC4100 and MC4100grxB during glucose starvation.
Extracellular protein concentration was determined in MC4100 (
) and
MC4100grxB (
) grown for a longer period of time in
minimal salt medium.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
S as the transcriptional regulator, and
the cAMP/CRP-connected specific response to glucose starvation (37).
Our results suggest that the levels of Grx2 are regulated in the
stationary phase by ppGpp in combination with
S. Grx2
expression also seems to be regulated by
70; Levels of
Grx2 in an rpoS
strain were almost
higher than in the wild type rather than lower as one would expect if
RpoS was the exclusive
factor for Grx2. Therefore, there are two
options for the regulation of Grx2 by ppGpp. ppGpp can be either a
direct effector by binding to the
70-RNA polymerase
holoenzyme (exponential phase), or it may influence the grxB
transcription indirectly by induction of
S (stationary
phase). Our data suggest that the exclusive induction of
S is not sufficient for grxB expression.
ppGpp is additionally required as a positive regulator of
S-dependent expression of Grx2. A
similar case has been described for the regulation of the
uspB gene expression (38).
S, so the effect on Grx2 is more likely to be indirect
through down-regulation of
S. Up-regulation of
S could potentially explain the higher levels of Grx2
after hyperosmotic treatment (32) and the increased transcription of
the gene under acidic conditions (39). However, hyperosmotic treatment
of
S-regulated genes could also be independent of
S (40, 41). The expression profile of Grx2 seems thus
similar to that of OsmY, another stationary phase protein osmotically regulated, requiring E
S for its expression, with basal
levels transcribed by E
70. OsmY, however, contains
cAMP-CMP binding sites at its promoter, which inhibit the initiation of
its transcription by the complex (42, 43).
strain (44). A global analysis of
E. coli transcripts up-regulated by hydrogen peroxide did
not include Grx2 (Grx3 or Trx1), but Grx1 and Trx2 (45). Therefore, the
regulation of Grx2 suggests that the protein is mainly involved in the
response to stationary phase conditions.
cells at the
stationary phase imply a vital yet unknown function for Grx2. The
three-dimensional structure of the molecule may provide some hints.
Grx2 shows close structural similarities to the glutathione
S-transferase family of proteins (6), the human glutathione
transferase omega 1 (GSTO1) (46), the mouse glutathione transferase
theta-like stress response protein (p28) (47), and the human chloride
intracellular channel 1 (CLIC1) (48). Common structural characteristics
are a two-domain structure, the first domain being a thioredoxin fold
domain in which the active site residues, and the second domain an
-helical structure. All these proteins are detoxifying or stress
response proteins. The similarities to CLIC1, belonging to a family of
proteins involved with forming chloride channels in intracellular
membranes or are chloride channel modulators (48), provides the
interesting possibility that Grx2 may be involved in osmoregulation,
especially after the up-regulation of Grx2 by hyperosmosis. Another
potential function for the up-regulation of Grx2 at the stationary
phase could be the alleviation of the host responses to E. coli. Grx2 prevents apoptosis in rat neurons by activating the
binding activity of NF-
B via Ref-1 (49). Grx2 can actually affect
both the Ras/phosphoinotiside 3-kinase/Akt/NF-
B and the JNK1/2/AP1
cascades (50). When growing in LB 10% of total Grx2 can be detected
extracellularly after 24 h of growth (data not shown). It is
therefore tempting to envisage an anti-inflammatory role of this
protein in relation to symbiosis with the host. The up-regulation of
Grx2 transcription under acidic conditions (39) also points to a host
defense adaptation. Clearly, more work is needed to elucidate the role
of E. coli Grx2.
| |
ACKNOWLEDGEMENTS |
|---|
We are grateful to Anne Farewell, Thomas Nyström, Anna Karin Pernerstig, Reginne Hengge-Aronis, and Micheal Cashel for plasmids and strains. We thank Silke Nicklisch for work related with the survival of the grxB null mutants and Annie Kolb for stimulating discussions.
| |
FOOTNOTES |
|---|
* This work was supported by grants from the Wenner-Gren foundation, the Swedish Cancer Society (Grant 961), the Karolinska Institute, the Knut and Alice Wallenberg Foundation, and by a research project of the European Communion in the cell factory area (QLRT-1999-00533, B104-CT98-0167).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed: Medical Nobel Inst. for Biochemistry, Dept. of Medical Biochemistry and Biophysics, Karolinska Inst., S-171 77 Stockholm, Sweden. Tel.: 46-8-728; Fax: 46-8-305193; E-mail: arne.holmgren@mbb.ki.se.
Published, JBC Papers in Press, March 11, 2002, DOI 10.1074/jbc.M201306200
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
RR, ribonucleotide reductase;
ELISA, enzyme-linked immunosorbent assay;
Grx, glutaredoxin;
ppGpp, guanosine-3',5'-tetraphosphate;
S or RpoS, rpoS-encoded sigma factor S;
Trx, thioredoxin;
PAPS, 3'-phosphoadenylylsulfate;
IPTG, isopropyl-1-thio-
-D-galactopyranoside;
CRP, catabolite
repressor protein.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Holmgren, A.
(1989)
J. Biol. Chem.
264,
13963-13966 |
| 2. |
Holmgren, A.,
and Åslund, F.
(1995)
Methods Enzymol.
252,
283-292[Medline]
[Order article via Infotrieve] |
| 3. |
Martin, J. L.
(1995)
Structure
3,
245-250[Medline]
[Order article via Infotrieve] |
| 4. |
Lillig, C. H.,
Prior, A.,
Schwenn, J. D.,
Åslund, F.,
Ritz, D.,
Vlamis-Gardikas, A.,
and Holmgren, A.
(1999)
J. Biol. Chem.
274,
7695-7698 |
| 5. |
Vlamis-Gardikas, A.,
Åslund, F.,
Spyrou, G.,
Bergman, T.,
and Holmgren, A.
(1997)
J. Biol. Chem.
272,
11236-11243 |
| 6. |
Xia, B.,
Vlamis-Gardikas, A.,
Holmgren, A.,
Wright, P. E.,
and Dyson, H. J.
(2001)
J. Mol. Biol.
310,
907-918[CrossRef][Medline]
[Order article via Infotrieve] |
| 7. |
Shi, J.,
Vlamis-Gardikas, A.,
Åslund, F.,
Holmgren, A.,
and Rosen, B. P.
(1999)
J. Biol. Chem.
274,
36039-36042 |
| 8. |
Vlamis-Gardikas, A.,
Potamitou, A.,
Zarivach, R.,
Hochman, A.,
and Holmgren, A.
(2002)
J. Biol. Chem.
277,
10861-10868 |
| 9. |
Holmgren, A.
(2000)
Antioxid. Redox Signal
2,
811-820[Medline]
[Order article via Infotrieve] |
| 10. |
Carmel-Harel, O.,
and Storz, G.
(2000)
Annu. Rev. Microbiol.
54,
439-461[CrossRef][Medline]
[Order article via Infotrieve] |
| 11. |
Ritz, D.,
and Beckwith, J.
(2001)
Annu. Rev. Microbiol.
55,
21-48[CrossRef][Medline]
[Order article via Infotrieve] |
| 12. |
Tao, K.
(1997)
J. Bacteriol.
179,
5967-5970 |
| 13. |
Ritz, D.,
Patel, H.,
Doan, B.,
Zheng, M.,
Åslund, F.,
Storz, G.,
and Beckwith, J.
(2000)
J. Biol. Chem.
275,
2505-2512 |
| 14. |
Becker-Hapak, M.,
and Eisenstark, A.
(1995)
FEMS Microbiol. Lett.
134,
39-44[Medline]
[Order article via Infotrieve] |
| 15. |
Åslund, F.,
Zheng, M.,
Beckwith, J.,
and Storz, G.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
6161-6165 |
| 16. |
Zheng, M.,
Aslund, F.,
and Storz, G.
(1998)
Science
279,
1718-1721 |
| 17. | Potamitou, A., Holmgren, A., and Vlamis-Gardikas, A. (2002) J. Biol. Chem. 277, in press |
| 18. | Cashel, M., Gentry, D. R., Hernandez, V. J., and D., V. (1996) in Eschericha coli and Salmonella (Neidhardt, F. C., ed), 2nd Ed., Vol. 1 , pp. 1458-1496, ASM Press, Washington, D. C. |
| 19. | Hengge-Aronis, R. (1996) in Escherichia coli and Salmonella (Neidhardt, F. C., ed), 2nd Ed., Vol. 1 , pp. 1497-1525, ASM Press, Washington, D. C. |
| 20. |
Lim, C.,
Daws, T.,
Gerami-Nejad, M.,
and Fuchs, J. A.
(2000)
Biochim. Biophys. Acta
1491,
1-6[Medline]
[Order article via Infotrieve] |
| 21. | Miller, J. H. (1992) A Short Course in Bacterial Genetics , Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY |
| 22. | Davis, R. W., Botstein, D., and Roth, J. R. (1980) Advanced Bacterial Genetics , Cold Spring Harbor Laboratory, Cold Spring Harbor, NY |
| 23. |
Teich, A.,
Meyer, S.,
Lin, H. Y.,
Andersson, L.,
Enfors, S.,
and Neubauer, P.
(1999)
Biotechnol. Prog.
15,
123-129[CrossRef][Medline]
[Order article via Infotrieve] |
| 24. |
Bradford, M. M.
(1976)
Anal. Biochem.
72,
248-254[CrossRef][Medline]
[Order article via Infotrieve] |
| 25. |
Sarubbi, E.,
Rudd, K. E.,
and Cashel, M.
(1988)
Mol. Gen. Genet.
213,
214-222[CrossRef][Medline]
[Order article via Infotrieve] |
| 26. |
Schreiber, G.,
Metzger, S.,
Aizenman, E.,
Roza, S.,
Cashel, M.,
and Glaser, G.
(1991)
J. Biol. Chem.
266,
3760-3767 |
| 27. |
Gentry, D. R.,
Hernandez, V. J.,
Nguyen, L. H.,
Jensen, D. B.,
and Cashel, M.
(1993)
J. Bacteriol.
175,
7982-7989 |
| 28. |
Kvint, K.,
Farewell, A.,
and Nystrom, T.
(2000)
J. Biol. Chem.
275,
14795-14798 |
| 29. |
Schweder, T.,
Lee, K. H.,
Lomovskaya, O.,
and Matin, A.
(1996)
J. Bacteriol.
178,
470-476 |
| 30. |
Lange, R.,
and Hengge-Aronis, R.
(1994)
Genes Dev.
8,
1600-1612 |
| 31. |
Lange, R.,
and Hengge-Aronis, R.
(1991)
Mol. Microbiol.
5,
49-59[Medline]
[Order article via Infotrieve] |
| 32. |
Hengge-Aronis, R.
(1996)
Mol. Microbiol.
21,
887-893[CrossRef][Medline]
[Order article via Infotrieve] |
| 33. |
Christman, M. F.,
Morgan, R. W.,
Jacobson, F. S.,
and Ames, B. N.
(1985)
Cell
41,
753-762[CrossRef][Medline]
[Order article via Infotrieve] |
| 34. |
Dukan, S.,
and Nyström, T.
(1998)
Genes Dev.
12,
3431-3441 |
| 35. |
Loewen, P. C.
(1979)
Can. J. Biochem.
57,
107-111[Medline]
[Order article via Infotrieve] |
| 36. |
Loewen, P. C.,
von Ossowski, I.,
Switala, J.,
and Mulvey, M. R.
(1993)
J. Bacteriol.
175,
2150-2153 |
| 37. |
Loewen, P. C., Hu, B.,
Strutinsky, J.,
and Sparling, R.
(1998)
Can. J. Microbiol.
44,
707-717[CrossRef][Medline]
[Order article via Infotrieve] |
| 38. |
Farewell, A.,
Kvint, K.,
and Nyström, T.
(1998)
Mol. Microbiol.
29,
1039-1051[CrossRef][Medline]
[Order article via Infotrieve] |
| 39. |
Arnold, C. N.,
McElhanon, J.,
Lee, A.,
Leonhart, R.,
and Siegele, D. A.
(2001)
J. Bacteriol.
183,
2178-2186 |
| 40. |
Bianchi, A. A.,
and Baneyx, F.
(1999)
Mol. Microbiol.
34,
1029-1038[CrossRef][Medline]
[Order article via Infotrieve] |
| 41. |
Hengge-Aronis, R.,
Lange, R.,
Henneberg, N.,
and Fischer, D.
(1993)
J. Bacteriol.
175,
259-265 |
| 42. |
Yim, H. H.,
Brems, R. L.,
and Villarejo, M.
(1994)
J. Bacteriol.
176,
100-107 |
| 43. |
Colland, F.,
Barth, M.,
Hengge-Aronis, R.,
and Kolb, A.
(2000)
EMBO J.
19,
3028-3037[CrossRef][Medline]
[Order article via Infotrieve] |
| 44. |
Monje-Casas, F.,
Jurado, J.,
Prieto-Alamo, M. J.,
Holmgren, A.,
and Pueyo, C.
(2001)
J. Biol. Chem.
276,
18031-18037 |
| 45. |
Zheng, M.,
Wang, X.,
Templeton, L. J.,
Smulski, D. R.,
LaRossa, R. A.,
and Storz, G.
(2001)
J. Bacteriol.
183,
4562-4570 |
| 46. |
Board, P. G.,
Coggan, M.,
Chelvanayagam, G.,
Easteal, S.,
Jermiin, L. S.,
Schulte, G. K.,
Danley, D. E.,
Hoth, L. R.,
Griffor, M. C.,
Kamath, A. V.,
Rosner, M. H.,
Chrunyk, B. A.,
Perregaux, D. E.,
Gabel, C. A.,
Geoghegan, K. F.,
and Pandit, J.
(2000)
J. Biol. Chem.
275,
24798-24806 |
| 47. |
Kodym, R.,
Calkins, P.,
and Story, M.
(1999)
J. Biol. Chem.
274,
5131-5137 |
| 48. |
Dulhunty, A.,
Gage, P.,
Curtis, S.,
Chelvanayagam, G.,
and Board, P.
(2001)
J. Biol. Chem.
276,
3319-3323 |
| 49. |
Daily, D.,
Vlamis-Gardikas, A.,
Offen, D.,
Mittelman, L.,
Melamed, E.,
Holmgren, A.,
and Barzilai, A.
(2001)
J. Biol. Chem.
276,
1335-1344 |
| 50. |
Daily, D.,
Vlamis-Gardikas, A.,
Offen, D.,
Mittelman, L.,
Melamed, E.,
Holmgren, A.,
and Barzilai, A.
(2001)
J. Biol. Chem.
276,
21618-21626 |
This article has been cited by other articles:
![]() |
C. Lelong, K. Aguiluz, S. Luche, L. Kuhn, J. Garin, T. Rabilloud, and J. Geiselmann The Crl-RpoS Regulon of Escherichia coli Mol. Cell. Proteomics, April 1, 2007; 6(4): 648 - 659. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Fernandes, M. Fladvad, C. Berndt, C. Andresen, C. H. Lillig, P. Neubauer, M. Sunnerhagen, A. Holmgren, and A. Vlamis-Gardikas A Novel Monothiol Glutaredoxin (Grx4) from Escherichia coli Can Serve as a Substrate for Thioredoxin Reductase J. Biol. Chem., July 1, 2005; 280(26): 24544 - 24552. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Lillig, A. Potamitou, J.-D. Schwenn, A. Vlamis-Gardikas, and A. Holmgren Redox Regulation of 3'-Phosphoadenylylsulfate Reductase from Escherichia coli by Glutathione and Glutaredoxins J. Biol. Chem., June 13, 2003; 278(25): 22325 - 22330. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Cheung, V. Badarinarayana, D. W. Selinger, D. Janse, and G. M. Church A Microarray-Based Antibiotic Screen Identifies a Regulatory Role for Supercoiling in the Osmotic Stress Response of Escherichia coli Genome Res., February 1, 2003; 13(2): 206 - 215. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||